in research - Abstract: RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells.

CONCLUSIONS: Our data provides kinase targets that could be exploited to design better therapeutics for ovarian cancer patients. We also demonstrate the effectiveness of high-throughput RNAi screening as a tool for identifying sensitizing targets to known and established chemotherapeutic agents.